论文部分内容阅读
目的在非麻醉下应用高强度超声聚焦治疗子宫肌瘤患者,探究其临床疗效。方法回顾性分析该院自2016年3—10月期间所收治的29例48个子宫肌瘤患者的临床资料,所有患者均非麻醉下进行超声聚焦治疗,分析其治疗效果。结果治疗后3、6、12个月复查,治疗6个月后的肌瘤体积由(37.2±6.7)cm3、缩小至(19.5±5.3)cm3,差异有统计学意义(P<0.05)。治疗后3、6、12个月患者的UFS评分和QOL评分亦明显优于治疗前,治疗6个月UFS评分由(35.65±2.44)分减至(22.75±4.25)分,QOL评分由(76.45±9.38)分增加至(100±8.45)分。可见随时间推移UFS逐渐减轻,QOL逐渐提高,差异有统计学意义(P<0.05)。结论应用非麻醉下超声聚焦治疗子宫肌瘤患者,治疗的临床疗效较为显著。
Objective To apply high-intensity ultrasound to treat patients with uterine fibroids under non-anesthetic and explore its clinical efficacy. Methods The clinical data of 29 patients with 48 myoma of uterus treated in our hospital from March to October of 2016 were retrospectively analyzed. All patients underwent non-anesthesia ultrasound focused treatment and analyzed the therapeutic effect. Results After 3,6 and 12 months of treatment, the fibroids volume decreased from (37.2 ± 6.7) cm3 to (19.5 ± 5.3) cm3 after 6 months of treatment, with significant difference (P <0.05). The UFS score and QOL score at 3, 6 and 12 months after treatment were also significantly better than those before treatment. The UFS score decreased from (35.65 ± 2.44) points to (22.75 ± 4.25) points and the QOL score from (76.45) to ± 9.38) points to (100 ± 8.45) points. Visible UFS gradually reduced over time, QOL gradually increased, the difference was statistically significant (P <0.05). Conclusion The application of non-anesthetic ultrasound focused on patients with uterine fibroids, the clinical efficacy of treatment was more significant.